{"id":"W2394805951","doi":"10.1158/1538-7445.sabcs15-p5-14-01","title":"Abstract P5-14-01: A meta-analysis of clinical benefit rates for fulvestrant 500 mg versus alternative therapies for treatment of postmenopausal, estrogen receptor-positive advanced breast cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Fulvestrant; Medicine; Internal medicine; Oncology; Anastrozole; Odds ratio; Breast cancer; Clinical trial; Cancer; Confidence interval; Randomized controlled trial; Progression-free survival; Gynecology; Estrogen receptor; Tamoxifen; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009126856,0.0004466769,0.002565134,0.0004957863,0.0001428502,0.00001732408,0.0003363526,0.0001747753,0.001611012],"category_scores_gemma":[0.000172879,0.0002691607,0.001597936,0.0007478526,0.0008505039,0.0002420535,0.00004601352,0.0001499765,0.000003730917],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008318097,"about_ca_system_score_gemma":0.0008885935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001385082,"about_ca_topic_score_gemma":0.0006964381,"domain_scores_codex":[0.996097,0.0001616508,0.001132716,0.0009303729,0.0008501209,0.0008281221],"domain_scores_gemma":[0.9920785,0.003591071,0.0006366216,0.0007112103,0.002676946,0.0003055907],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.1022785,0.001285681,0.002960252,0.0002503042,0.301277,0.00000771251,0.00142908,0.000445911,0.2983608,0.0009883859,0.00008990747,0.2906265],"study_design_scores_gemma":[0.05322834,0.01984051,0.06061659,0.0005605598,0.1045675,0.000007826504,0.002015324,0.000112732,0.7456618,0.001769539,0.01061347,0.001005842],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9442551,0.02703766,0.0005728326,0.005398069,0.0003446455,0.003892533,0.01840327,0.00003683792,0.00005902741],"genre_scores_gemma":[0.9832557,0.007275529,0.002669285,0.00005730211,0.0004634328,0.005285737,0.00012848,0.0001056327,0.0007588284],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.447301,"threshold_uncertainty_score":0.999976,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2738566685408791,"score_gpt":0.534350758404024,"score_spread":0.2604940898631449,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}